IL-17 antagonists (Vipergen)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameIL-17 antagonists (Vipergen)

Drug Alias Namevpc-00443

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-17 inhibitors

TargetsInterleukin-17

Therapy Area/IndicationsInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVipergen APS

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVipergen APS

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune Diseases

ATC CodeN/A